Checkpoint Therapeutics (CKPT) Stock Chart & Stock Price History → 30-day gains? (From TradeSmith) (Ad) Free CKPT Stock Alerts $1.58 +0.10 (+6.76%) (As of 05/3/2024 ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainabilityStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaSustainability Checkpoint Therapeutics Stock Price Performance5 Day Performance+13.67%1 Month Performance-13.66%3 Month Performance-14.59%6 Month Performance-19.80%Year-To-Date Performance-31.00%1 Year Performance-47.68% Receive CKPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressNever use this word on your phone (FBI could be watching)This report sent a chill down my spine. Turns out, as part of their Jan. 6th investigation, the Feds are flagging Americans who typed these ordinary words as part of their banking transactions...Watch my unredacted video about what I think is coming next right here CKPT Stock Chart for Sunday, May, 5, 2024 CKPT Chart by TradingView Checkpoint Therapeutics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/03/2024$1.48$1.58+6.76%$1.70$1.47614,307 shs$56.39 million05/02/2024$1.40$1.48+5.71%$1.51$1.39324,599 shs$52.82 million05/01/2024$1.39$1.40+0.72%$1.44$1.38174,166 shs$49.97 million04/30/2024$1.44$1.39-3.14%$1.47$1.39177,198 shs$49.61 million04/29/2024$1.43$1.44+0.35%$1.53$1.42341,006 shs$51.21 million04/26/2024$1.42$1.43+0.70%$1.46$1.39541,824 shs$51.04 million Get the Latest News and Ratings for CKPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 04/25/2024$1.44$1.42-1.39%$1.50$1.41166,048 shs$50.68 million04/24/2024$1.44$1.44+0.35%$1.48$1.42183,824 shs$51.39 million04/23/2024$1.45$1.44-1.03%$1.52$1.42352,028 shs$51.22 million04/22/2024$1.46$1.45-0.68%$1.54$1.41458,413 shs$51.75 million04/19/2024$1.60$1.46-8.75%$1.68$1.45755,018 shs$52.11 million04/18/2024$1.67$1.60-4.19%$1.72$1.59469,359 shs$57.10 million04/17/2024$1.69$1.67-1.18%$1.72$1.66267,826 shs$59.60 million04/16/2024$1.72$1.69-1.74%$1.77$1.66506,930 shs$60.32 million04/15/2024$1.78$1.72-3.37%$1.76$1.68469,215 shs$61.38 million04/12/2024$1.83$1.78-2.73%$1.86$1.75271,968 shs$63.53 million04/11/2024$1.78$1.83+2.81%$1.86$1.76300,312 shs$65.31 million04/10/2024$1.83$1.78-2.73%$1.83$1.76353,710 shs$63.53 million04/09/2024$1.82$1.83+0.55%$1.88$1.78249,995 shs$65.31 million04/08/2024$1.83$1.82-0.55%$1.89$1.77305,688 shs$64.96 million04/05/2024$1.87$1.83-2.14%$1.94$1.82371,395 shs$65.31 million04/04/2024$1.92$1.87-2.60%$1.95$1.85262,256 shs$66.74 million04/03/2024$1.92$1.92$1.96$1.90243,655 shs$68.53 million04/02/2024$2.02$1.92-4.95%$2.01$1.89305,408 shs$68.53 million04/01/2024$2.05$2.02-1.46%$2.08$2.00356,864 shs$47.52 million03/29/2024$2.05$2.05$2.10$2.02345,753 shs$48.24 million03/28/2024$2.04$2.05+0.49%$2.10$2.02345,753 shs$48.24 million03/27/2024$2.07$2.04-1.45%$2.10$2.00251,912 shs$48.00 million03/26/2024$2.00$2.07+3.50%$2.15$2.00471,163 shs$48.71 million03/25/2024$1.94$2.00+3.09%$2.06$1.92450,034 shs$47.06 million03/22/2024$1.90$1.94+2.11%$1.99$1.85493,118 shs$45.65 million03/21/2024$1.88$1.90+1.06%$1.95$1.87410,454 shs$44.70 million03/20/2024$1.85$1.88+1.62%$1.92$1.80377,861 shs$44.24 million03/19/2024$1.89$1.85-2.12%$1.94$1.85341,091 shs$43.53 million03/18/2024$1.92$1.89-1.56%$2.01$1.87392,309 shs$44.47 million03/15/2024$1.85$1.92+3.78%$1.94$1.88378,608 shs$45.18 million03/14/2024$1.95$1.85-5.13%$2.01$1.85401,662 shs$43.53 million03/13/2024$2.00$1.95-2.50%$2.09$1.95316,347 shs$45.88 million03/12/2024$2.15$2.00-6.98%$2.15$2.00272,879 shs$47.06 million03/11/2024$2.14$2.15+0.70%$2.23$2.11343,147 shs$50.59 million55x Gains Instead of 9x Gains (Ad)We’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-up before it’s too late. It’s urgent because it’s what we consider “The #1 Crypto for the AI World.”Learn more about it by watching THIS NOW.03/08/2024$2.17$2.14-1.61%$2.24$2.12272,592 shs$50.24 million03/07/2024$2.21$2.17-1.81%$2.21$2.11251,776 shs$51.05 million03/06/2024$2.23$2.21-0.90%$2.35$2.18362,457 shs$52.00 million03/05/2024$2.32$2.23-3.88%$2.34$2.20385,258 shs$52.47 million03/04/2024$2.23$2.32+4.04%$2.33$2.20569,292 shs$54.59 million03/01/2024$2.09$2.23+6.70%$2.33$2.10613,490 shs$52.47 million02/29/2024$2.05$2.09+1.95%$2.15$2.07243,451 shs$49.18 million02/28/2024$2.14$2.05-4.21%$2.14$2.02467,863 shs$48.24 million02/27/2024$2.04$2.14+4.90%$2.18$2.02764,365 shs$50.35 million02/26/2024$1.96$2.04+4.08%$2.05$1.92394,682 shs$48.00 million02/23/2024$1.88$1.96+4.26%$2.03$1.87693,446 shs$46.12 million02/22/2024$1.92$1.88-2.08%$1.95$1.87477,003 shs$44.23 million02/21/2024$1.98$1.92-3.03%$2.01$1.90376,292 shs$45.18 million02/20/2024$2.01$1.98-1.49%$2.05$1.94421,092 shs$46.59 million02/19/2024$2.01$2.01$2.06$1.97455,000 shs$47.30 million02/16/2024$2.01$2.01$2.06$1.97454,685 shs$47.30 million02/15/2024$1.99$2.01+1.01%$2.06$1.97503,021 shs$47.30 million02/14/2024$1.90$1.99+4.74%$2.03$1.91438,136 shs$46.83 million02/13/2024$1.99$1.90-4.52%$1.97$1.88622,052 shs$44.71 million02/12/2024$2.00$1.99-0.50%$2.08$1.95806,820 shs$46.83 million02/09/2024$1.99$2.00+0.50%$2.02$1.94359,715 shs$47.06 million02/08/2024$1.93$1.99+3.11%$2.02$1.91361,480 shs$46.83 million02/07/2024$2.00$1.93-3.50%$2.03$1.91360,834 shs$45.41 million02/06/2024$1.85$2.00+8.11%$2.05$1.84609,022 shs$47.06 million02/05/2024$1.92$1.85-3.65%$1.93$1.80509,307 shs$43.53 million Related Companies: Gain Therapeutics Stock Chart Aadi Bioscience Stock Chart Equillium Stock Chart HCW Biologics Stock Chart Eagle Pharmaceuticals Stock Chart BioLineRx Stock Chart Nabriva Therapeutics Stock Chart Lantern Pharma Stock Chart Clene Stock Chart Reneo Pharmaceuticals Stock Chart Receive CKPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Checkpoint Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CKPT) was last updated on 5/5/2024 by MarketBeat.com Staff From Our PartnersBiden to Launch “FedNOW” [Move Your Money Now]Priority GoldElon to Transform U.S. Economy? Porter & CompanyAutomatic Income (from home)Awesomely, LLCCould Your Accounts Be Frozen?Allegiance GoldThe asset beating inflation by 4xColonial MetalsUrgent Nvidia WarningAltimetryThe A.I. story nobody is telling you (Read ASAP)TradeSmithWarren Buffet Stockpiling Gold?Reagan Gold Group Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Checkpoint Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.